Ameriprise Financial Inc. grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 112.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 442,661 shares of the company’s stock after acquiring an additional 234,010 shares during the period. Ameriprise Financial Inc. owned about 0.28% of Henry Schein worth $36,293,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of the business. SG Americas Securities LLC acquired a new position in shares of Henry Schein in the third quarter worth $1,047,000. Commonwealth Equity Services Inc grew its stake in shares of Henry Schein by 97.4% in the third quarter. Commonwealth Equity Services Inc now owns 6,838 shares of the company’s stock worth $560,000 after acquiring an additional 3,374 shares in the last quarter. Ashfield Capital Partners LLC grew its stake in shares of Henry Schein by 90.1% in the third quarter. Ashfield Capital Partners LLC now owns 81,679 shares of the company’s stock worth $6,697,000 after acquiring an additional 38,704 shares in the last quarter. RKL Wealth Management LLC grew its stake in shares of Henry Schein by 72.8% in the third quarter. RKL Wealth Management LLC now owns 45,552 shares of the company’s stock worth $3,730,000 after acquiring an additional 19,185 shares in the last quarter. Finally, Thompson Investment Management Inc. grew its stake in shares of Henry Schein by 74.2% in the third quarter. Thompson Investment Management Inc. now owns 13,500 shares of the company’s stock worth $1,107,000 after acquiring an additional 5,750 shares in the last quarter. Institutional investors and hedge funds own 91.68% of the company’s stock.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.19% of the stock is owned by insiders.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The company had revenue of $3.16 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period last year, the firm earned $0.84 earnings per share. Henry Schein’s revenue was up 10.3% on a year-over-year basis. equities analysts predict that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein announced that its Board of Directors has authorized a share repurchase plan on Monday, September 18th that authorizes the company to repurchase $400.00 million in shares. This repurchase authorization authorizes the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board of directors believes its shares are undervalued.
A number of brokerages recently commented on HSIC. Royal Bank Of Canada lowered their target price on shares of Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a research note on Tuesday, November 7th. Jefferies Group reiterated a “hold” rating and set a $89.00 target price on shares of Henry Schein in a research note on Friday, October 20th. Credit Suisse Group reiterated a “hold” rating and set a $87.50 target price on shares of Henry Schein in a research note on Tuesday, August 29th. Stephens began coverage on shares of Henry Schein in a research note on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 target price for the company. Finally, Leerink Swann reiterated a “market perform” rating and set a $77.00 target price (down previously from $87.50) on shares of Henry Schein in a research note on Tuesday, November 7th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $88.36.
TRADEMARK VIOLATION NOTICE: “Ameriprise Financial Inc. Boosts Holdings in Henry Schein, Inc. (HSIC)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/12/03/ameriprise-financial-inc-boosts-holdings-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.